###begin article-title 0
###xml 85 90 <span type="species:ncbi:9606">Women</span>
Peripheral Mononuclear Cell Resistin mRNA Expression Is Increased in Type 2 Diabetic Women
###end article-title 0
###begin p 1
Recommended by V. L. Petricevich
###end p 1
###begin p 2
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 538 542 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 548 553 545 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 628 629 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 742 743 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 806 807 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 817 818 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 852 853 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 863 864 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1053 1057 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1063 1068 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 103 109 <span type="species:ncbi:9606">humans</span>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 387 392 <span type="species:ncbi:9606">human</span>
###xml 449 454 <span type="species:ncbi:9606">women</span>
###xml 621 626 <span type="species:ncbi:9606">women</span>
###xml 735 740 <span type="species:ncbi:9606">women</span>
###xml 977 982 <span type="species:ncbi:9606">women</span>
###xml 1254 1262 <span type="species:ncbi:9606">patients</span>
Resistin has been shown to cause insulin resistance and to impair glucose tolerance in rodents, but in humans its physiological role still remains elusive. The aim of this study was to examine whether resistin mRNA expression in human peripheral mononuclear cells (PBMCs) and its corresponding plasma levels are altered in type 2 diabetes. Resistin mRNA levels were easily detectable in human PBMC, and found to be higher in DM2 compared to healthy women (P = .05). Similarly, mononuclear mRNA levels of the proinflammatory cytokines IL-1beta, TNF-alpha, and IL-6 were all significantly higher in DM2 compared to control women (P < .001). The corresponding plasma resistin levels were slightly, but not significantly, increased in DM2 women (P = .051), and overall, they correlated significantly with BMI (r = 0.406, P = .010) and waist circumference (r = 0.516, P = .003), but not with fasting insulin levels or HOMA-IR. Resistin mRNA expression is increased in PBMC from DM2 women, together with increased expression of the inflammatory cytokines IL-1beta, TNF-alpha, and IL-6, independent of obesity. These results suggest that resistin and cytokines might contribute to the low-grade inflammation and the increased atherogenic risk observed in these patients.
###end p 3
###begin title 4
1. INTRODUCTION
###end title 4
###begin p 5
###xml 69 74 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 269 270 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 272 273 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 479 480 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 482 483 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 701 706 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 789 790 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 792 793 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 907 908 899 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1053 1054 1045 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1167 1172 1159 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1178 1182 1166 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1266 1267 1251 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 1269 1270 1254 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 929 935 <span type="species:ncbi:9606">humans</span>
Resistin and other molecules commonly called adipokines, such as TNF-alpha, IL-6, and visfatin, are produced and secreted by both adipocytes and macrophages, and have been suggested to be important players in the pathogenesis of insulin resistance and atherosclerosis [1, 2]. Increased production of these adipokines occurs with expanding obesity, particularly visceral obesity, by both the adipocytes and the nonfat cells, mostly macrophages that infiltrate the adipose tissue [3, 4]. Indeed, the common origin of macrophages and adipocytes has been well documented as well as their overlapping biology and function (accumulation of lipids, expression and secretion of similar cytokines, such as TNF-alpha, IL-6, resistin, visfatin, and expression of genes involved in lipid metabolism) [4, 5]. Furthermore, recruitment and accumulation of macrophages in the adipose tissue are characteristics of obesity [6]. Interestingly, in humans, the expression of resistin and visfatin is predominantly detected in the macrophages populating the adipose tissue [7]. Several studies have also demonstrated increased expression and release of the proinflammatory cytokines, TNF-alpha, IL-1beta, and IL-6, from the adipocytes or the macrophages infiltrating the adipose tissue [3, 7].
###end p 5
###begin p 6
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 407 412 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 443 448 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 469 470 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 584 585 576 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 587 589 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 881 883 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 903 908 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 1097 1102 1085 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 1113 1115 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1117 1119 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 234 239 <span type="species:ncbi:9606">human</span>
###xml 529 535 <span type="species:ncbi:9606">humans</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
###xml 740 748 <span type="species:ncbi:9606">patients</span>
Notably, resistin belongs to a family of molecules called found in inflammatory zone (FIZZ), since a member of this family was found to be expressed in bronchial epithelial cells during allergic pulmonary inflammation in mice [8]. In human mononuclear cells, where resistin is highly expressed, its expression is markedly upregulated by lipopolysaccharide (LPS) and the proinflammatory cytokines (Il-6, TNF-alpha, and IL-1), acting via the NF-kappaB-dependent pathway [9]. Furthermore, intravenous administration of endotoxin in humans markedly increased circulating resistin levels [9, 10]. In agreement with these experimental data, patients with severe inflammatory disease have significantly higher serum resistin concentrations, while patients with rheumatoid arthritis (RA) show increased resistin levels in their inflamed joints that correlate with markers of inflammation [11]. Furthermore, PPARgamma agonists and HMG-CoA reductase inhibitors (statins), both recognized for their anti-inflammatory properties, decrease macrophage resistin mRNA and protein secretion, apparently via the NF-kappaB pathway [12, 13].
###end p 6
###begin p 7
###xml 97 102 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 108 112 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 220 225 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 330 332 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 412 414 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 775 777 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 904 906 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1098 1100 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1102 1104 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1216 1218 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 159 165 <span type="species:ncbi:10090">murine</span>
###xml 393 398 <span type="species:ncbi:9606">human</span>
###xml 896 902 <span type="species:ncbi:9606">humans</span>
###xml 917 925 <span type="species:ncbi:9606">patients</span>
###xml 1090 1096 <span type="species:ncbi:9606">humans</span>
###xml 1206 1214 <span type="species:ncbi:9606">children</span>
Consistent with the proinflammatory nature of resistin, human resistin powerfully stimulates TNF-alpha, IL-1beta, IL-6, and IL-12 expression in human PBMC and murine macrophages, an effect that can be abrogated by an NF-kappaB inhibitor, indicating the importance of this signalling pathway in the resistin-mediated inflammation [14]. Resistin was also shown to increase lipid accumulation in human macrophages [15]. Resistin also acts on endothelial cells and promotes their activation, by inducing the expression and release of monocyte chemoattractant protein (MCP)-1, endothelin-1 (ET-1), and adhesion molecules, such as vascular cell adhesion molecule -1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1), while at the same time adiponectin abrogates this effect [16]. Moreover, resistin is secreted by the macrophages localizing to the atheromas, thereby promoting atherosclerosis in humans [17]. Indeed, patients with coronary artery disease (CAD) have higher serum resistin levels that correlate with markers of inflammation, and are predictive of coronary atherosclerosis in humans [18, 19]. High serum resistin levels have also been proposed as predictors of early atherosclerosis in obese children [20].
###end p 7
###begin p 8
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 155 161 <span type="species:ncbi:9606">humans</span>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 410 415 <span type="species:ncbi:9606">human</span>
While resistin's role as an inflammatory marker in human's and rodent's physiology has been well documented, its role in obesity and insulin resistance in humans is still under debate. It is important that human resistin is expressed in much higher levels in macrophages than in adipocytes [21], quite the opposite from the case of mice, in which resistin clearly impairs insulin sensitivity [22, 23]. Several human studies have failed to confirm any relationship of circulating resistin levels with BMI, insulin sensitivity, or other metabolic parameters [24-26]. However, there have been reports of increased serum resistin levels in individuals with obesity and/or type 2 diabetes [27-29].
###end p 8
###begin p 9
###xml 55 60 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 76 80 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 98 103 <span type="species:ncbi:9606">human</span>
In the present study, we examined whether resistin TNF-alpha, IL-6, and IL-1beta mRNA levels from human peripheral mononuclear cells are altered in type 2 diabetes and whether they correlate with circulating resistin levels and with indices of obesity or insulin resistance.
###end p 9
###begin title 10
2. SUBJECTS AND METHODS
###end title 10
###begin title 11
2.1. Subjects
###end title 11
###begin p 12
###xml 416 423 416 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 126 131 <span type="species:ncbi:9606">women</span>
###xml 430 435 <span type="species:ncbi:9606">women</span>
###xml 641 646 <span type="species:ncbi:9606">women</span>
###xml 792 797 <span type="species:ncbi:9606">woman</span>
The study was approved by the "Alexandra" Hospital Ethical Committee and all subjects gave informed consent. Forty eight (48) women, all premenopausal, aged between 21 and 49 years, participated in our study. Twenty two had type 2 diabetes (DM2), and twenty six were healthy controls with normal glucose tolerance (NGT). Both groups were further divided into two groups: those with BMI < 27 and those with BMI > 27 (Table 1). All women have had a stable weight, and they were on a normal eucaloric diet and normal physical activity, not participating in any specific exercise program for the last three months preceding the test. Of the DM2 women, 15 were on diet alone, 4 on oral hypoglycaemic agents, 2 on insulin, and 1 on combined insulin and oral hypoglycaemic agents. No DM2 or healthy woman was on thiazolidinedione or statin medication. All control subjects had no history of endocrine abnormality and were on no medications.
###end p 12
###begin p 13
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 194 196 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
Body mass index (BMI) was calculated as the ratio of body weight (Kg) per height (m2). Insulin resistance was calculated by the homeostasis model assessment index (HOMA-IR) as [fasting insulin (muU/mL) x fasting glucose (mmol/L)]/22.5. Insulin sensitivity was calculated by the Matsuda index as (10 000/sqare root of [fasting glucose x fasting insulin] x [mean glucose during OGTT x mean insulin during OGTT]). Fasting glucose, triglycerides, and free fatty acid (FFA) levels were analyzed on a Falcor 300 Chemical Analyser (Menarini Diagnostics, Italy) and fasting plasma insulin levels were measured by IRMA (INSI-CTK, DiaSorin, Italy), in all individuals. 
###end p 13
###begin title 14
2.2. RNA preparation
###end title 14
###begin p 15
###xml 40 45 <span type="species:ncbi:9606">women</span>
Peripheral blood was collected from all women after an overnight fast and the mononuclear cells were separated using a Histopaque-1077 gradient (Sigma-Aldrich, USA). At the same time, plasma was kept at -80degreesC for subsequent measurement of adipokines.
###end p 15
###begin p 16
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 520 524 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 530 535 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 566 571 <span type="species:ncbi:9606">human</span>
The mononuclear cells were then left to adhere for 1 hour for the selective isolation of the primary monocyte-derived macrophages, and total RNA was extracted from cells as previously described [30]. Briefly, after the RNA isolation, cDNA synthesis was performed in all samples using oligo random primers (NEB, Mass, USA) and MMLV reverse transcriptase (Promega Corp., Wis, USA) [30]. We developed a quantitative real-time PCR using fluorescently labeled hybridization probes to detect resistin and proinflammatory (IL-1beta, TNF-alpha, and IL-6) mRNA expression in human mononuclear cells, in a spectrofluorometric thermal cycler (LightCycler, ROCHE, Mannheim, Germany).
###end p 16
###begin title 17
2.3. Primer design
###end title 17
###begin p 18
###xml 231 238 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
Hybridization-specific primers and hybridization-specific probes for all genes were designed and manufactured by the (TIB MOLBIOL Berlin, Germany). Hybridization primers and probes for all target and reference genes were showen in Table 2.
###end p 18
###begin p 19
###xml 165 169 <span type="species:ncbi:307630">Colo</span>
Primers were chosen to lie between exons whenever possible and the analysis was performed basically with the program OLIGO 6.0 (Molecular Biology Insights, Cascade, Colo, USA).
###end p 19
###begin title 20
2.4. Quantitative real-time PCR
###end title 20
###begin p 21
###xml 272 276 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 282 287 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 481 483 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 817 821 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 927 931 917 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 789 794 <span type="species:ncbi:9606">human</span>
Relative quantification is the method that determines the changes in steady-state mRNA levels of a gene across various samples and expresses them relative to the levels of an internal reference control gene, usually a housekeeping gene. In order to quantify resistin, IL-1beta, TNF-alpha, and IL-6 relative mRNA levels, we used the calibrator-normalized standard curve and the LightCycler Relative Quantification 1.0.1 Software (Roche, Mannheim, Germany), as previously described [30]. Briefly, using this quantification method, results are expressed as the target/reference ratio of the sample divided by the target/reference ratio of the calibrator, and it does not require a standard curve in each run (Roche Applied Science, Technical Note No. LC 13/2001-Relative Quantification). The human housekeeping genes of beta-actin and porphobilinogen deaminase (PBGD) were used as standards for normalization. Selection of either beta-actin or PBGD as housekeeping genes was necessary because the copy number of the housekeeping gene should be in a similar range with that of the target gene to make comparative quantification possible (Roche Applied Science, Technical Note No. LC 15/2002-Selection of Housekeeping Genes). Thus, the PBGD house keeping gene was chosen for the relative quantification of the IL-6 mRNA expression because of the very low level of IL-6 expression in the calibrator (HL60 induced with phorbol myristyl acetate (PMA)) mRNA.
###end p 21
###begin p 22
###xml 77 81 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 87 92 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 128 132 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Standard curves describing the PCR efficiencies of the target (resistin, IL-1beta, TNF-alpha, or IL-6) and the reference genes (beta-actin or PBGD) were created from a dilution series of the calibrator cDNA, using the Second derivative maximum method with the arithmetic baseline adjustment. The second derivative maximum method was used for the determination of the various crossing points (Cps) of the target and the reference gene in each sample. Finally, a corresponding coefficient file was created, which determines the efficiency for the target and the reference gene. Amplification of each sample was performed in triplicate, in different runs, and fluorescence resulting from the close proximity of the annealed hybridization probes was detected at the end of the annealing step of each PCR cycle.
###end p 22
###begin p 23
The results from different PCR runs were run randomly in ethidium bromide-stained agarose gels and photographed in an Image Analyser VDS System (Amersham-Pharmacia Biotech, Sweden).
###end p 23
###begin p 24
###xml 0 12 0 12 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="25">Immunoassays</title>
###xml 77 82 77 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 291 295 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 576 580 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 689 693 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 12 706 12 693 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="26">Circulating levels of resistin (BioVender, Canal zone, USA), TNF-<italic>&#945;</italic> (R&amp;D Systems, UK), and IL-6 (R&amp;D Systems, UK) were measured in the plasma of all women, using standard commercial enzyme-linked immunosorbent assays according to the manufacturers'-recommended protocols. IL-1<italic>&#946;</italic> circulating protein levels were measured in the plasma of all women, using a high sensitivity multiplex assay (xMAP technology) and the fluorescently labeled microsphere beads (Linco-Millipore Corp., USA), in a LUMINEX 200 instrument (Luminex Corp., USA). We could not detect IL-1<italic>&#946;</italic> in the majority of our subjects (in 57% of controls and 55% of DM2), making the analysis of circulating IL-1<italic>&#946;</italic> problematic.</p>
###xml 781 786 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 826 830 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 955 960 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1007 1011 983 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 706 1053 693 1026 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="27">The sensitivities of the assays were 0.2 ng/mL (resistin), 0.12 pg/mL (TNF-<italic>&#945;</italic>), &lt;0.094 pg/mL (IL-6), 0.06 pg/mL (IL-1<italic>&#946;</italic>), the intra- and the interassay coefficients of variation were, respectively, 3.6% and 6.7% (resistin), 6.6% and 13.4% (TNF-<italic>&#945;</italic>), 6.9% and 14.1% (IL-6), 3.11% and 2.16% (IL-1<italic>&#946;</italic>). All samples were measured in duplicate.</p>
###xml 0 1053 0 1026 <statement xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="head1"><title textid="25">Immunoassays</title><p textid="26">Circulating levels of resistin (BioVender, Canal zone, USA), TNF-<italic>&#945;</italic> (R&amp;D Systems, UK), and IL-6 (R&amp;D Systems, UK) were measured in the plasma of all women, using standard commercial enzyme-linked immunosorbent assays according to the manufacturers'-recommended protocols. IL-1<italic>&#946;</italic> circulating protein levels were measured in the plasma of all women, using a high sensitivity multiplex assay (xMAP technology) and the fluorescently labeled microsphere beads (Linco-Millipore Corp., USA), in a LUMINEX 200 instrument (Luminex Corp., USA). We could not detect IL-1<italic>&#946;</italic> in the majority of our subjects (in 57% of controls and 55% of DM2), making the analysis of circulating IL-1<italic>&#946;</italic> problematic.</p><p textid="27">The sensitivities of the assays were 0.2 ng/mL (resistin), 0.12 pg/mL (TNF-<italic>&#945;</italic>), &lt;0.094 pg/mL (IL-6), 0.06 pg/mL (IL-1<italic>&#946;</italic>), the intra- and the interassay coefficients of variation were, respectively, 3.6% and 6.7% (resistin), 6.6% and 13.4% (TNF-<italic>&#945;</italic>), 6.9% and 14.1% (IL-6), 3.11% and 2.16% (IL-1<italic>&#946;</italic>). All samples were measured in duplicate.</p></statement>
###xml 164 169 <span type="species:ncbi:9606">women</span>
###xml 358 363 <span type="species:ncbi:9606">women</span>
ImmunoassaysCirculating levels of resistin (BioVender, Canal zone, USA), TNF-alpha (R&D Systems, UK), and IL-6 (R&D Systems, UK) were measured in the plasma of all women, using standard commercial enzyme-linked immunosorbent assays according to the manufacturers'-recommended protocols. IL-1beta circulating protein levels were measured in the plasma of all women, using a high sensitivity multiplex assay (xMAP technology) and the fluorescently labeled microsphere beads (Linco-Millipore Corp., USA), in a LUMINEX 200 instrument (Luminex Corp., USA). We could not detect IL-1beta in the majority of our subjects (in 57% of controls and 55% of DM2), making the analysis of circulating IL-1beta problematic.The sensitivities of the assays were 0.2 ng/mL (resistin), 0.12 pg/mL (TNF-alpha), <0.094 pg/mL (IL-6), 0.06 pg/mL (IL-1beta), the intra- and the interassay coefficients of variation were, respectively, 3.6% and 6.7% (resistin), 6.6% and 13.4% (TNF-alpha), 6.9% and 14.1% (IL-6), 3.11% and 2.16% (IL-1beta). All samples were measured in duplicate.
###end p 24
###begin title 25
Immunoassays
###end title 25
###begin p 26
###xml 65 70 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 279 283 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 564 568 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 677 681 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 152 157 <span type="species:ncbi:9606">women</span>
###xml 346 351 <span type="species:ncbi:9606">women</span>
Circulating levels of resistin (BioVender, Canal zone, USA), TNF-alpha (R&D Systems, UK), and IL-6 (R&D Systems, UK) were measured in the plasma of all women, using standard commercial enzyme-linked immunosorbent assays according to the manufacturers'-recommended protocols. IL-1beta circulating protein levels were measured in the plasma of all women, using a high sensitivity multiplex assay (xMAP technology) and the fluorescently labeled microsphere beads (Linco-Millipore Corp., USA), in a LUMINEX 200 instrument (Luminex Corp., USA). We could not detect IL-1beta in the majority of our subjects (in 57% of controls and 55% of DM2), making the analysis of circulating IL-1beta problematic.
###end p 26
###begin p 27
###xml 75 80 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 120 124 116 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 249 254 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 301 305 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
The sensitivities of the assays were 0.2 ng/mL (resistin), 0.12 pg/mL (TNF-alpha), <0.094 pg/mL (IL-6), 0.06 pg/mL (IL-1beta), the intra- and the interassay coefficients of variation were, respectively, 3.6% and 6.7% (resistin), 6.6% and 13.4% (TNF-alpha), 6.9% and 14.1% (IL-6), 3.11% and 2.16% (IL-1beta). All samples were measured in duplicate.
###end p 27
###begin title 28
2.5. Statistical analysis
###end title 28
###begin p 29
###xml 133 134 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 296 297 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Statistical analysis was performed using the SPSS version 14.0.1 software (Chicago, Ill, USA). Data are expressed as mean +/- SEM of n-independent experiments. Nonparametric statistical analyses were applied (Spearman's correlation test and nonparametric Mann-Whitney test), where appropriate. A P-value of less than .05 was considered statistically significant.
###end p 29
###begin title 30
3. RESULTS
###end title 30
###begin title 31
3.1. Clinical characteristics of study subjects
###end title 31
###begin p 32
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 70 75 <span type="species:ncbi:9606">women</span>
###xml 243 248 <span type="species:ncbi:9606">women</span>
Table 1 shows the clinical characteristics of the DM2 and healthy NGT women, who were further divided into two subgroups according to their BMI, one with BMI < 27 and one with BMI > 27. The groups were generally well matched between them. DM2 women, however, had significantly higher waist circumference, triglyceride and FFA levels, and lower HDL cholesterol levels compared to the BMI-matched controls.
###end p 32
###begin p 33
###xml 14 19 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 31 35 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:9606">women</span>
Resistin, TNF-alpha, IL-6, IL-1beta mRNA expression from human mononuclear-monocytic cells is elevated in DM2 women.
###end p 33
###begin p 34
###xml 189 190 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 219 230 215 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1(a)</xref>
###xml 311 318 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 102 107 <span type="species:ncbi:9606">women</span>
Resistin mRNA expression was easily detected in human mononuclear-monocytic cells in both DM2 and NGT women, and was significantly higher (0.57 +/- 0.1 versus 0.52 +/- 0.1 arbitrary units, P = .05) in the former group (Figure 1(a)), while no significant differences were observed between the two BMI subgroups (Table 3).
###end p 34
###begin p 35
###xml 4 9 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 29 33 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 187 188 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 238 239 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 307 308 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 334 338 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(b)</xref>
###xml 340 344 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(c)</xref>
###xml 350 354 319 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(d)</xref>
###xml 123 128 <span type="species:ncbi:9606">women</span>
###xml 145 150 <span type="species:ncbi:9606">women</span>
TNF-alpha, IL-6 mRNA and IL-1beta mRNA levels were significantly higher (approximately10-, 15-, and 10-fold, resp.) in DM2 women compared to NGT women [0.34 +/- 0.1 versus 0.03 +/- 0.01 (P < .001), 342.98 +/- 127.9 versus 21.64 +/- 12.6 (P < .001), and 139.36 +/- 40.2 versus 13.21 +/- 7.8 arbitrary units (P = .001), resp.] (Figures 1(b), 1(c), and 1(d)).
###end p 35
###begin p 36
###xml 64 68 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 78 83 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 98 99 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 109 110 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 121 122 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 132 133 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 166 171 159 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 229 230 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 240 241 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 289 293 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 307 308 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 318 319 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 331 332 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 342 343 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 392 393 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 403 404 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 416 417 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 427 428 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 488 489 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 500 501 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 512 513 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 524 525 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 551 555 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 600 601 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 611 612 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 643 644 626 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 654 655 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 689 690 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 700 701 683 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 720 721 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 731 732 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 767 768 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 778 779 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 801 802 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 812 813 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 867 868 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 879 880 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Resistin mRNA levels correlated positively with mononuclear IL-1beta, and TNF-alpha, mRNA levels (r = 0.324, P < .05 and r = 0.447, P < .01, resp.). Furthermore, TNF-alpha and IL-6 mRNA levels correlated positively between them (r = 0.687, P < .001) and also each one of them with the IL-1beta mRNA levels (r = 0.767, P < .001 and r = 0.765, P < .001, resp.), the 2-hour OGTT glucose levels (r = 0.462, P = .005 and r = 0.486, P = .004, resp.) and negatively with HDL cholesterol levels (r = -0.367, P < .02 and r = -0.372, P < .02, resp.), while IL-1beta mRNA levels correlated positively with BMI (r = 0.374, P = .017), waist circumference (r = 0.414, P = .019), fasting glucose levels (r = 0.365, P = .022), HOMA-IR (r = 0.325, P = .043), glycosylated hemoglobin (r = 0.542, P = .001), FFA levels (r = 0.335, P = .043), and negatively with HDL cholesterol levels (r = -0.395, P = .015).
###end p 36
###begin title 37
###xml 31 36 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 52 56 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
3.2. Circulating resistin, TNF-alpha, IL-6, and IL-1beta protein levels
###end title 37
###begin p 38
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 120 128 120 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 223 228 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 244 248 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 329 337 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 391 396 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 469 476 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab4">Table 4</xref>
###xml 72 77 <span type="species:ncbi:9606">women</span>
###xml 102 107 <span type="species:ncbi:9606">women</span>
###xml 322 327 <span type="species:ncbi:9606">women</span>
###xml 462 467 <span type="species:ncbi:9606">women</span>
Plasma resistin levels tended to be overall significantly higher in DM2 women compared to NGT control women (P = .051) (Figure 2), but no significant differences were observed between the two BMI subgroups. Circulating TNF-alpha, IL-6, and IL-1beta protein levels did not differentiate between the DM2 and the NGT-control women (Figure 2), although in the subgroup of DM2 with BMI > 27, TNF-alpha and IL-6 plasma levels were significantly higher compared to NGT women (Table 4).
###end p 38
###begin p 39
###xml 83 87 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 105 106 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 116 117 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 129 130 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 140 141 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 153 154 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 164 165 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 211 212 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 222 223 219 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 235 236 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 246 247 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 326 331 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 405 406 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 416 417 409 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 429 430 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 440 441 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 453 454 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 464 465 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 477 478 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 488 489 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Circulating resistin correlated positively with mononuclear resistin, IL-6 and IL-1beta mRNA expression (r = 0.526, P = .001 and r = 0.354, P = .029 and r = 0.425, P = .009, resp.), BMI and waist circumference (r = 0.406, P = .010 and r = 0.516, P = .003), but not with HOMA-IR, fasting insulin, or glucose plasma levels. TNF-alpha and IL-6 plasma levels also correlated with BMI and waist circumference (r = 0.361, P = .013 and r = 0.651, P < .001 and r = 0.379, P = .023 and r = 0.676, P < .001, resp.) as well as with fasting glucose, insulin and triglyceride levels, the HOMA-IR, while they correlated negatively with the Matsuda index and HDL cholesterol levels.
###end p 39
###begin title 40
4. DISCUSSION
###end title 40
###begin p 41
###xml 240 244 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 250 255 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 140 145 <span type="species:ncbi:9606">women</span>
###xml 175 180 <span type="species:ncbi:9606">women</span>
We have demonstrated that resistin mRNA expression from human peripheral monocyte-enriched mononuclear cells is elevated in type 2 diabetic women, compared to healthy control women, in parallel with significant increases in mononuclear IL-1beta, TNF-alpha, and IL-6 mRNA expression.
###end p 41
###begin p 42
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 576 581 576 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 639 644 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 665 667 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 669 671 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 998 1000 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1002 1004 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1005 1007 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 326 332 <span type="species:ncbi:9606">humans</span>
###xml 476 482 <span type="species:ncbi:9606">humans</span>
###xml 498 503 <span type="species:ncbi:9606">human</span>
###xml 599 604 <span type="species:ncbi:9606">human</span>
###xml 609 615 <span type="species:ncbi:10090">murine</span>
###xml 818 826 <span type="species:ncbi:9606">patients</span>
###xml 867 875 <span type="species:ncbi:9606">patients</span>
Resistin, a 12.5-kDa cysteine-rich adipokine, which was shown to cause insulin resistance and to impair glucose tolerance in rodents [1], is also highly expressed in human mononuclear cells and macrophages [21]. While in rodents, adipocyte-produced resistin is mainly involved in glucose metabolism and insulin resistance: in humans, monocyte-produced resistin seems to have potent proinflammatory properties. Various inflammatory stimuli could result in hyperresistinemia in humans [9, 10], while human resistin can stimulate the expression of the inflammatory cytokines TNF-alpha and IL-6 in both human and murine macrophages, via an NF-kappaB-dependent pathway [11, 14]. The proinflammatory nature of resistin was further documented by the findings that serum resistin concentrations were significantly elevated in patients with severe inflammatory disease and in patients with previous myocardial infarction, in whom they positively correlated with markers of inflammation, independent of CRP [11, 18-20].
###end p 42
###begin p 43
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 993 995 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:9606">women</span>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
###xml 814 819 <span type="species:ncbi:9606">human</span>
###xml 1129 1134 <span type="species:ncbi:9606">human</span>
In the present study, we have demonstrated that resistin mRNA levels from human peripheral monocyte-enriched mononuclear cells were higher in the DM2 compared to healthy women, which was independent of BMI. It should be noted that the difference did not reach significance between the individuals groups, but only when all patients were grouped together in NGT and DM2. This is obviously due to the small number of individuals used in our study, which is a weakness of our data. The above overall difference may suggest that, unlike inflammatory cytokine mRNA expression from human mononuclear cells, mononuclear resistin mRNA is not appreciably increased in vivo with chronic hyperinsulinemia that characterizes obesity. In support of this, in vitro studies demonstrated that insulin decreases resistin mRNA from human monocytes [31], while in the 3T3-L1 adipocytes, insulin downregulated resistin mRNA and protein secretion-possibly through the PI 3-kinase, ERK, or p38 MAP-kinase pathways-[32]. Recently, however, another study demonstrated that acute hyperinsulinemia is associated with increased resistin mRNA expression in human subcutaneous adipose tissue and a similar increase in plasma resistin levels [33].
###end p 43
###begin p 44
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 405 410 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 964 965 960 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 838 843 <span type="species:ncbi:9606">human</span>
Macrophages and adipocytes share an overlapping biology and function [4], and infiltration of the adipose tissue with the macrophages is characteristic of obesity [6]. Several recent studies suggest that obesity is associated with an increase in adipose tissue macrophages, which also participate in the inflammatory process through the elaboration of cytokines [3, 4, 34]. Proinflammatory cytokines (TNF-alpha and IL-6) and adipokines (resistin and visfatin), produced by the peripheral macrophages, can also be expressed in increased amounts in the fat tissue of obese individuals acting in parallel as important regulators of inflammation, atherosclerosis, and insulin sensitivity in both tissues. In a recent study, the expression of two adipokines, resistin, and visfatin was detected predominantly in the macrophages populating the human visceral fat tissue, suggesting that these adipokines might have an important role in the inflammatory load of obesity [7].
###end p 44
###begin p 45
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1125 1127 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 854 860 <span type="species:ncbi:9606">humans</span>
###xml 976 982 <span type="species:ncbi:9606">humans</span>
The putative role of resistin in obesity-induced insulin resistance was confirmed by studies, in rodents, demonstrating that administration of recombinant resistin impairs hepatic insulin sensitivity and glucose metabolism [22], while possibly playing a role in maintaining fasting blood glucose levels [23]. This was debated by various human studies demonstrating that there is no relationship of circulating resistin levels with BMI, insulin sensitivity, or other metabolic parameters [24-26]. However, other studies found increased serum resistin levels in individuals with obesity and/or type 2 diabetes [27-29]. The above conflicting data lead to the ascertainment that despite the initial belief that resistin could be the factor linking obesity and type 2 diabetes, its biologic significance in the pathogenesis of insulin resistance, at least in humans, is under controversy [35]. In fact, while in rodents adipose tissue is the only source of resistin production, in humans resistin is barely detectable in adipocytes, and actual resistin mRNA levels are much higher in monocytes and macrophages than in adipocytes [21].
###end p 45
###begin p 46
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 907 911 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1036 1040 1033 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1119 1123 1113 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1214 1216 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1218 1220 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 1307 1311 1298 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1383 1388 1371 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1762 1767 1746 1747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1893 1898 1873 1874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1939 1941 1915 1917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1943 1945 1919 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 128 133 <span type="species:ncbi:9606">women</span>
###xml 154 159 <span type="species:ncbi:9606">women</span>
###xml 773 778 <span type="species:ncbi:9606">women</span>
###xml 881 889 <span type="species:ncbi:9606">patients</span>
###xml 974 979 <span type="species:ncbi:9606">women</span>
###xml 1458 1463 <span type="species:ncbi:9606">women</span>
###xml 1551 1556 <span type="species:ncbi:9606">women</span>
###xml 1602 1607 <span type="species:ncbi:9606">women</span>
###xml 1929 1937 <span type="species:ncbi:9606">patients</span>
In the present study, we have additionally demonstrated that plasma resistin levels are marginally increased in type 2 diabetic women compared to healthy women, and this increase was detected in both subgroups, those with BMI < 27 and those with BMI > 27. Thus, our data are inline with previous reports that found elevated serum resistin levels in type 2 diabetic subjects compared with nondiabetic subjects [28, 29, 36]. Nevertheless, we observed no correlation of circulating resistin with insulin resistance indices. However, the observed positive correlation of circulating resistin with BMI and waist circumference might support some association of resistin with obesity-induced insulin resistance. Therefore, the observed increased plasma resistin levels in the DM2 women could be due to the increased visceral obesity, as it reveals the higher waist circumference of these patients. Circulating Il-1beta did not differentiate between the healthy control and the DM2 women, a result that lines with previous studies in which Il-1beta alone cannot associate with the risk of developing type 2 diabetes, while Il-1beta was even decreased in an impaired glucose tolerance (IGT) group compared to NGT subjects [37, 38]. It should be emphasized that due to the large number of subjects in whom plasma IL-1beta levels were undetectable, they should be interpreted with caution. TNF-alpha and IL-6 plasma levels were also similar between the NGT and the DM2 women of our study, although their levels are significantly increased in the subgroup of DM2 women with BMI > 27, compared to NGT with BMI < 27 women; moreover, they were significantly correlated with the obesity and insulin resistance indices. While in the EPIC-Potsdam study the elevated levels of TNF-alpha and IL-6 were found to be strongly associated with future type 2 diabetes, other studies failed to demonstrate increased TNF-alpha and IL-6 plasma levels in DM2 patients [37, 39]. The above discrepancy could be due to the small number of subjects used in the later study, as it was also in our case, and due to ethnic differences between the various studies.
###end p 46
###begin p 47
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 684 689 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 705 709 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 903 905 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1458 1462 1451 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1468 1473 1458 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 896 901 <span type="species:ncbi:9606">women</span>
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
###xml 1262 1268 <span type="species:ncbi:9606">humans</span>
###xml 1614 1622 <span type="species:ncbi:9606">patients</span>
Obesity-induced insulin resistance is characterized by a chronic, systemic low-grade state of inflammation and is strongly associated with inflammatory markers, while inflammation may contribute to insulin resistance and atherosclerosis [2, 5, 40]. Therefore, with expanding obesity and increased macrophage infiltration of the adipose tissue, there is an increased cytokine production by both cell populations, with all the detrimental metabolic consequences on insulin resistance and on the inflammatory status [4, 6, 41]. In the present study, we have demonstrated that in type 2 diabetes, there is an increased mRNA expression of resistin, along with significant increases in TNF-alpha, IL-6, and Il-1beta mRNA expression by the peripheral circulating mononuclear cells. The results from this study, together with previous data, showing higher mononuclear visfatin mRNA expression in the DM2 women [30], suggest that an overload of mRNA expression of inflammatory cytokines and adipokines occurs in the mononuclear cells from type 2 diabetic patients, aggravating the proinflammatory status of this condition. These data further support the notion that the peripheral circulating mononuclear cells can indeed be an important source of resistin production in humans. Thus, in type 2 diabetes, macrophages that infiltrate the stroma of the adipose tissue and/or the vascular endothelium can locally produce and secrete increased resistin and cytokine (Il-1beta, TNF-alpha, and IL-6) levels, which may enhance the inflammatory load and the associated insulin resistance and vascular dysfunction observed in these patients. 
###end p 47
###begin title 48
ACKNOWLEDGMENTS
###end title 48
###begin p 49
The authors would like to thank Professor J. Papamatheakis (Institute of Molecular Biology and Biotechnology, University of Crete, Heraklion, Greece) for kindly providing them with the HL60 cell line. This work was supported by the General Secretariat for Research and Technology of Greece, EPET II-Subprogram IV-PENED99 (99EDelta207).
###end p 49
###begin article-title 50
The hormone resistin links obesity to diabetes
###end article-title 50
###begin article-title 51
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
###end article-title 51
###begin article-title 52
###xml 60 65 <span type="species:ncbi:9606">human</span>
Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells
###end article-title 52
###begin article-title 53
Role of macrophage tissue infiltration in metabolic diseases
###end article-title 53
###begin article-title 54
Inflammation, stress, and diabetes
###end article-title 54
###begin article-title 55
Obesity is associated with macrophage accumulation in adipose tissue
###end article-title 55
###begin article-title 56
###xml 15 20 <span type="species:ncbi:9606">human</span>
Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin
###end article-title 56
###begin article-title 57
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family
###end article-title 57
###begin article-title 58
###xml 56 62 <span type="species:ncbi:9606">humans</span>
An inflammatory cascade leading to hyperresistinemia in humans
###end article-title 58
###begin article-title 59
###xml 40 46 <span type="species:ncbi:9606">humans</span>
Innate immunity modulates adipokines in humans
###end article-title 59
###begin article-title 60
Resistin, an adipokine with potent proinflammatory properties
###end article-title 60
###begin article-title 61
###xml 139 147 <span type="species:ncbi:9606">patients</span>
Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients
###end article-title 61
###begin article-title 62
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes
###end article-title 62
###begin article-title 63
###xml 61 66 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 98 103 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway
###end article-title 63
###begin article-title 64
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human resistin promotes macrophage lipid accumulation
###end article-title 64
###begin article-title 65
Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions
###end article-title 65
###begin article-title 66
Resistin is secreted from macrophages in atheromas and promotes atherosclerosis
###end article-title 66
###begin article-title 67
###xml 57 63 <span type="species:ncbi:9606">humans</span>
Resistin is an inflammatory marker of atherosclerosis in humans
###end article-title 67
###begin article-title 68
Cross-sectional associations of resistin, coronary heart disease, and insulin resistance
###end article-title 68
###begin article-title 69
###xml 47 55 <span type="species:ncbi:9606">children</span>
Determinants of early atherosclerosis in obese children and adolescents
###end article-title 69
###begin article-title 70
###xml 73 78 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 25 30 <span type="species:ncbi:9606">human</span>
Resistin is expressed in human macrophages and directly regulated by PPARgamma activators
###end article-title 70
###begin article-title 71
###xml 64 68 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production
###end article-title 71
###begin article-title 72
Regulation of fasted blood glucose by resistin
###end article-title 72
###begin article-title 73
###xml 28 33 <span type="species:ncbi:9606">human</span>
Resistin gene expression in human adipocytes is not related to insulin resistance
###end article-title 73
###begin article-title 74
###xml 85 91 <span type="species:ncbi:9606">humans</span>
Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects
###end article-title 74
###begin article-title 75
###xml 81 87 <span type="species:ncbi:9606">humans</span>
Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans
###end article-title 75
###begin article-title 76
###xml 53 59 <span type="species:ncbi:9606">humans</span>
Serum resistin (FIZZ3) protein is increased in obese humans
###end article-title 76
###begin article-title 77
Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus
###end article-title 77
###begin article-title 78
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus
###end article-title 78
###begin article-title 79
###xml 14 19 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 100 105 <span type="species:ncbi:9606">women</span>
Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women
###end article-title 79
###begin article-title 80
###xml 84 89 <span type="species:ncbi:9606">human</span>
Effects of glucose, insulin and leptin on resistin mRNA and protein production from human peripheral monocytes
###end article-title 80
###begin article-title 81
Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes
###end article-title 81
###begin article-title 82
Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects
###end article-title 82
###begin article-title 83
###xml 53 58 <span type="species:ncbi:9606">human</span>
Adipokines oversecreted by omental adipose tissue in human obesity
###end article-title 83
###begin article-title 84
###xml 46 49 <span type="species:ncbi:9606">men</span>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Resistin: yet another adipokine tells us that men are not mice
###end article-title 84
###begin article-title 85
Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes
###end article-title 85
###begin article-title 86
Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
###end article-title 86
###begin article-title 87
Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects
###end article-title 87
###begin article-title 88
###xml 40 45 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness
###end article-title 88
###begin article-title 89
Inflammation: the link between insulin resistance, obesity and diabetes
###end article-title 89
###begin article-title 90
###xml 98 103 <span type="species:ncbi:9606">human</span>
Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue
###end article-title 90
###begin p 91
###xml 42 46 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 74 79 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 80 84 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 143 147 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 148 152 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 252 253 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 244 249 <span type="species:ncbi:9606">women</span>
###xml 271 276 <span type="species:ncbi:9606">women</span>
 (a) Bar graphs compare relative resistin/beta-actin mRNA levels, (b) TNF-alpha/beta-actin mRNA levels, (c) IL-6/PBGD mRNA levels, and (d) IL-1beta/beta-actin mRNA levels, from peripheral mononuclear-enriched monocytes from NGT-control and DM2 women. *P < .05 versus NGT-women.
###end p 91
###begin p 92
###xml 40 45 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 61 65 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 129 130 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 121 126 <span type="species:ncbi:9606">women</span>
###xml 149 154 <span type="species:ncbi:9606">women</span>
Comparison of circulating resistin, TNF-alpha, IL-6, and IL-1beta protein levels between the NGT-healthy control and DM2 women. *P < .051 versus NGT-women.
###end p 92
###begin p 93
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients' characteristics, their fasting glucose, fasting insulin, triglycerides, HDL and FFA levels, the HOMA-IR and Matsuda indices.
###end p 93
###begin p 94
###xml 15 16 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 44 56 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 56 57 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Mean +/- SEM: *P < .03 versus NGT-BMI < 27; section signP < .05 versus NGT-BMI > 27.
###end p 94
###begin p 95
###xml 23 28 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 44 48 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 131 136 <span type="species:ncbi:9606">women</span>
Relative resistin, TNF-alpha, IL-6, and IL-1beta mRNA levels from mononuclear cells between the subgroups of the NGT- and the DM2- women.
###end p 95
###begin p 96
###xml 32 33 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 70 82 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 82 83 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 63 68 <span type="species:ncbi:9606">women</span>
###xml 113 118 <span type="species:ncbi:9606">women</span>
Data expressed as mean +/- SE: *P < .017 versus NGT-(BMI < 27)-women; section signP < .013 versus NGT-(BMI > 27)-women.
###end p 96
###begin p 97
###xml 26 31 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 47 51 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 113 118 <span type="species:ncbi:9606">women</span>
Circulating resistin, TNF-alpha, IL-6, and IL-1beta protein levels between the subgroups of the NGT- and the DM2-women.
###end p 97
###begin p 98
###xml 32 33 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 70 82 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 82 83 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 63 68 <span type="species:ncbi:9606">women</span>
###xml 112 117 <span type="species:ncbi:9606">women</span>
Data expressed as mean +/- SE: *P < .015 versus NGT-(BMI < 27)-women; section signP < .05 versus NGT-(BMI > 27)-women.
###end p 98

